Catalyst Wire Dossier Catalyst Wire Dossier

KX01 Ointment 1%

KX01 Ointment 1% · PharmaEssentia
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KX01 Ointment 1%, covering 2024-04-19 to 2024-04-19. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp [Phase 3]

See pricing